The amended product information will provide more specific detail on encephalitis as a known adverse reaction to ...

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa ...

Clozapine blood monitoring can now be reduced to every 12 weeks after 1 year of treatment, and annually after 2 years, in patients without neutropenia.

On July 10, 2025, the Food and Drug Administration (FDA) announced that it had published more than 200 complete response letters (CRLs), in ...

In today's fast-paced world of artificial intelligence and enterprise technology, few leaders embody both technical depth and ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

HONG KONG] The biotechnology industry is experiencing a tectonic shift, driven by Chinese drugmakers who have come a long way ...

Most European travellers heading to sub-tropical regions know to make sure they're up to date on their vaccinations. While ...

Data obtained by CTV News from Health Canada shows that 85 per cent of inspections of drug manufacturing sites supplying the ...

Retail chatter around Crinetics Pharmaceuticals picked up late Sunday after the company released long-term data for its oral ...

Britain said it would strike an agreement with Vietnam to make it easier for pharmaceutical firms to sell UK-made medicines ...

HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ('HYTN” or the 'Company”), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce it has received a Cannabis Drug ...